Supplementary Table 1: Wound Healing Outcomes in Skin Cancer Patients on Sirolimus: Insights from Dermatologic Surgery

Published: 15 July 2025| Version 1 | DOI: 10.17632/22mdz5p3mp.1
Contributors:
Eva Shelton, Simran Kaur, Alexa Figueroa Baiges, Janmesh Patel, Michael Lasarev, Annika Weinhammer

Description

Supplementary Table 1. Complication rates by defect depth (dermis/fat, fascia, muscle, cartilage/bone) for tumors treated with sirolimus and tacrolimus. Includes relative risks and overall trends across increasing defect depths.

Files

Institutions

  • University of Wisconsin Madison Department of Dermatology
  • University of Wisconsin Madison School of Medicine and Public Health
  • University of Wisconsin Madison Department of Statistics

Categories

Wound Healing, Immunosuppression, Non-Melanoma Skin Cancer

Licence